Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of Shiga toxin-producing <i>E. coli</i> infection by CRISPR-Cas-targeted cleavage of the Shiga toxin gene in animal models.

Science translational medicine·2026
Same author

Innovations in Implant Osseointegration: Biomaterials, Surface Engineering, and Translational Strategies.

Journal of biomedical materials research. Part A·2026
Same author

STEVE: Single-cell Transcriptomics Expression Visualization and Evaluation.

bioRxiv : the preprint server for biology·2026
Same author

Cardiomyocyte-Specific modRNA-Induced FoxM1 Overexpression Promotes Recovery From Myocardial Infarction in Adult Mammals.

Circulation·2026
Same author

ETV2-ECSCR-mTOR pathways regulate reprogramming to the endothelial lineage.

Stem cells (Dayton, Ohio)·2026
Same author

Innovations in Bioactive Materials for Dental Pulp Vitality Preservation in Children and Adolescents.

Applied sciences (Basel, Switzerland)·2025

Related Experiment Video

Updated: Feb 25, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

10.9K

Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering.

Mounica Yanamandala1, Wuqiang Zhu2, Daniel J Garry3

  • 1Department of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York.

Journal of the American College of Cardiology
|August 5, 2017
PubMed
Summary

Stem cell therapy shows promise for heart repair, but challenges like poor cell integration persist. Tissue engineering offers a solution to improve cell survival and cardiac function after myocardial injury.

Keywords:
biocompatible materialsheart failuremyocardial infarctionmyocardiumstem cells

More Related Videos

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
11:09

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

11.6K
Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair
05:05

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Published on: June 9, 2020

6.0K

Related Experiment Videos

Last Updated: Feb 25, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

10.9K
Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
11:09

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

11.6K
Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair
05:05

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair

Published on: June 9, 2020

6.0K

Area of Science:

  • Regenerative Medicine
  • Biomedical Engineering
  • Cardiovascular Research

Background:

  • Stem cell transplantation has shown potential in animal models for improving cardiac performance after myocardial injury.
  • Clinical trials have yielded inconsistent results due to challenges such as poor cell engraftment and functional immaturity of transplanted cells, particularly human cardiomyocytes.
  • These limitations lead to reduced contribution to heart contractility and increased risks of arrhythmia.

Purpose of the Study:

  • To address the limitations of current stem cell therapy for myocardial injury.
  • To explore advanced tissue and genetic engineering techniques to enhance cell survival and integration.
  • To investigate the potential of prefabricated cardiac tissue patches for structural, functional, and bioenergetic recovery of infarcted hearts.

Main Methods:

  • Review of advances in tissue and genetic engineering techniques relevant to cardiac repair.
  • Focus on strategies to improve survival, integration, and electrical coupling of transplanted cells.
  • Evaluation of prefabricated cardiac tissue patches as a therapeutic approach.

Main Results:

  • Tissue and genetic engineering advancements are expected to improve transplanted cell survival and integration.
  • These techniques aim to support structural, functional, and bioenergetic recovery of the recipient heart.
  • Prefabricated cardiac tissue patches present a promising strategy to prevent cardiac dilation and enhance pumping efficiency.

Conclusions:

  • Overcoming challenges in cell engraftment and functional integration is crucial for successful stem cell therapy in cardiology.
  • Tissue engineering approaches, particularly cardiac tissue patches, offer a viable strategy to improve outcomes.
  • This approach holds promise for translating stem cell therapy into a clinical reality for treating myocardial infarction.